The quest for optimal and reliable guidelines based on robust evidence for the treatment of cholangiocarcinoma.
作者信息
Azoulay Daniel, Bomze David, Meirson Tomer
机构信息
Centre Hépato-Biliaire, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Paul Brousse, Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 935, and Université Paris-Saclay, Villejuif, France.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
出版信息
Hepatobiliary Surg Nutr. 2021 Dec;10(6):913-915. doi: 10.21037/hbsn-21-117.
Abstract
摘要
相似文献
1
The quest for optimal and reliable guidelines based on robust evidence for the treatment of cholangiocarcinoma.寻求基于确凿证据的胆管癌治疗的最佳且可靠的指南。
Hepatobiliary Surg Nutr. 2021 Dec;10(6):913-915. doi: 10.21037/hbsn-21-117.
2
The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines.美国和欧洲胆管癌的临床管理：指南的全面循证比较
Ann Surg Oncol. 2021 May;28(5):2660-2674. doi: 10.1245/s10434-021-09671-y. Epub 2021 Mar 1.
3
Treatment of Achalasia in the Evidence-Based Medicine Era - A Quest in Search for a Proper Attitude by Reviewing the Present Guidelines.循证医学时代贲门失弛缓症的治疗 - 通过审查现有指南寻求正确态度的探索。
Chirurgia (Bucur). 2022 Apr;117(2):154-163. doi: 10.21614/chirurgia.2732.
4
Does Adjuvant Therapy Benefit Low-Risk Resectable Cholangiocarcinoma? An Evaluation of the NCCN Guidelines.辅助治疗是否有益于低风险可切除的胆管癌？对 NCCN 指南的评估。
J Gastrointest Surg. 2023 Mar;27(3):511-520. doi: 10.1007/s11605-022-05558-9. Epub 2022 Dec 20.
5
The current management of cholangiocarcinoma: A comparison of current guidelines.胆管癌的现行治疗方法：现行指南比较。
Biosci Trends. 2016 May 23;10(2):92-102. doi: 10.5582/bst.2016.01048. Epub 2016 Mar 29.
6
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.肝内胆管癌诊断和管理指南
J Hepatol. 2014 Jun;60(6):1268-89. doi: 10.1016/j.jhep.2014.01.021. Epub 2014 Mar 27.
7
Radiomics nomogram based on optimal VOI of multi-sequence MRI for predicting microvascular invasion in intrahepatic cholangiocarcinoma.基于多序列 MRI 最佳感兴趣区的影像组学列线图预测肝内胆管细胞癌微血管侵犯。
Radiol Med. 2023 Nov;128(11):1296-1309. doi: 10.1007/s11547-023-01704-8. Epub 2023 Sep 7.
8
Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.局部区域型肝外胆管癌的多模态治疗：一项基于人群的分析。
Cancer. 2009 Nov 15;115(22):5175-83. doi: 10.1002/cncr.24572.
9
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment.意大利胆管癌临床实践指南 - 第二部分：治疗。
Dig Liver Dis. 2020 Dec;52(12):1430-1442. doi: 10.1016/j.dld.2020.08.030. Epub 2020 Sep 18.
10
Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.钇[90Y]微球放射性栓塞治疗不可切除的肝内胆管细胞癌。
Future Oncol. 2017 Jun;13(15):1301-1310. doi: 10.2217/fon-2017-0022. Epub 2017 Mar 27.
本文引用的文献
1
Systemic review of the robustness of randomized controlled trials for the treatment of cholangiocarcinoma in three domains: survival-inferred fragility index, restricted mean survival time, and the spin effect.对随机对照试验在治疗胆管癌方面在三个领域的稳健性进行的系统评价：生存推断脆弱性指数、受限平均生存时间和自旋效应。
Hepatobiliary Surg Nutr. 2022 Dec;11(6):861-869. doi: 10.21037/hbsn-21-118.
2
Appraisal of the current guidelines for management of cholangiocarcinoma-using the Appraisal of Guidelines Research and Evaluation II (AGREE II) Instrument.使用指南研究与评价工具II（AGREE II）对胆管癌现行管理指南的评估
Hepatobiliary Surg Nutr. 2020 Apr;9(2):126-135. doi: 10.21037/hbsn.2019.09.06.
3
Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.关于非转移性结直肠癌根治性治疗后随访的共识和争议：欧洲结直肠外科学会成员国指南摘要。
Colorectal Dis. 2019 Apr;21(4):392-416. doi: 10.1111/codi.14503. Epub 2019 Jan 3.
4
Evaluation of the current guidelines for resection of hepatocellular carcinoma using the Appraisal of Guidelines for Research and Evaluation II instrument.运用 AGREE II 工具评价肝细胞癌切除术的现行指南。
J Hepatol. 2017 Nov;67(5):991-998. doi: 10.1016/j.jhep.2017.06.028. Epub 2017 Jul 8.
5
Progress in evidence-based medicine: a quarter century on.循证医学的进展：二十五年的历程。
Lancet. 2017 Jul 22;390(10092):415-423. doi: 10.1016/S0140-6736(16)31592-6. Epub 2017 Feb 17.
6
Assessing the Gold Standard--Lessons from the History of RCTs.评估金标准——随机对照试验历史的教训
N Engl J Med. 2016 Jun 2;374(22):2175-81. doi: 10.1056/NEJMms1604593.
7
Systematic review of guidelines for management of intermediate hepatocellular carcinoma using the Appraisal of Guidelines Research and Evaluation II instrument.使用《指南研究与评价 II 工具》对中度肝细胞癌管理指南进行的系统评价。
Dig Liver Dis. 2015 Oct;47(10):877-83. doi: 10.1016/j.dld.2015.07.005. Epub 2015 Jul 15.
8
Users' guide to the surgical literature: how to evaluate clinical practice guidelines.外科文献用户指南：如何评估临床实践指南。
Can J Surg. 2014 Aug;57(4):280-6. doi: 10.1503/cjs.029612.
9
American Society of Clinical Oncology Clinical Practice Guidelines: formal systematic review-based consensus methodology.美国临床肿瘤学会临床实践指南：正式的基于系统评价的共识方法。
J Clin Oncol. 2012 Sep 1;30(25):3136-40. doi: 10.1200/JCO.2012.42.0489. Epub 2012 Jul 9.
10
The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies.过去二十年临床实践指南的质量：指南评估研究的系统综述
Qual Saf Health Care. 2010 Dec;19(6):e58. doi: 10.1136/qshc.2010.042077.
Zotero 插件